Sunteți pe pagina 1din 4

Dr. Somsak Leelang.

Ph.D.(BA), M.Pharm(SAP), B.Pharm(Hons).

Professional Licenses
Investment Consultant Complex 1 : 092311
Capital Market Investment Consultant License : 092311
Derivatives Investment Consultant License : 092311
Securities Investment Consultant License : 092311
Fund Investment Consultant License : 092311
Equity Investment Consultant License : 092311
Debt Instrument Investment Consultant License : 092311
Insurance Broker License : 6004036938
Life Insurance Broker License : 6103028095
Registered Pharmacist License : Bh. 19000
Type First Class Pharmacy No. : SKA 35/2550
Commercial Registration No. : 3 9103 00090 494

Contact Address : 104 Moo 2 soi 1 Taladmai road,


Padangbesar, Sadao, Songkhla, Thailand 90240.
Mobile Phone : 081-5412120
Line ID : 0815412120
E-mail : somasaka100@hotmail.com
Expertise : Drugs, Healthcare, Investments.

EDUCATION

Year Qualification

2004 Bachelor of Pharmacy (Honours) : B.Pharm (Hons.).


2004 Diploma in Technical Preparation of Chemotherapy,( PSU).
2013 Master of Pharmacy : M.Pharm (SAP).
2017 Doctor of Philosophy : Ph.D. (BA).
2017 Certificate in Money Management, (SET).
2017 Certificate in Retirement Planning, (SET).
2017 Certificate in Investment Principles, (SET).
2017 Certificate in New Enterpreneurs Creation, (CU).
2018 Certificate in Derivative Investment, (SET).
2018 Certificate in 21st Century Marketting, (CU).
2018 Certificate in Easy Online Derivative Investment, (SET).
2018 Certificate in Knowledge of SET50 & Stock Futures, (SET).
2018 Certificate in Knowledge of Options Investment Strategy, (SET).
2018 Certificate in Knowledge of Futures Investment Strategy, (SET).
2018 Certificate in Critical Thinking for Business, (CU).
2018 Certificate in Introduction to Criminal Law, (CU).
2018 Certificate in Introduction to Civil Law, (CU).
2018 Certificate in Upgrade English Epic: Complete Grammar, (CU).
2018 Certificate in Upgrade L1 Insurance Broker License, (TII).
2018 Certificate in Migration to IC Complex 1, (ATI-ASCO).
2018 Certificate in Final Grammar and Pronunciation, (CU).
2018 Certificate in Upgrade English Epic: Difficult Vocabulary , (CU).
2018 Certificate in The Use of IT for Professional skill , (NU).
2018 Certificate in English Conversation, (CU).
2018 Certificate in Understanding Financial Statement, (CU).
2018 Certificate in English for Cultural Tourism, (RMUTT).
2018 Certificate in Law for Business, (CU).
2018 Certificate in Pharmacotherapy in Chronic Kidney Disease, (NU).

Research Published

สมศักดิ หลีหลัง, ศุภรัตน์ แสงคุณะคุปต์. (2548). การเตรี ยมตํารั บยาแอมโฟเทอริ ซิน บี รู ปแบบไมเซลล์
สําหรั บนําส่ งสู่ระบบทางเดินหายใจ. รายงานการวิจยั , ภาควิชาเทคโนโลยีเภสัชกรรม, คณะเภสัช
ศาสตร์, มหาวิทยาลัยสงขลานคริ นทร์. หน้า 1-49
สมศักดิ หลีหลัง. (2556). ราคาต้นทุนยาของร้ านยาในจังหวัดสงขลา. สารนิพนธ์, ภาควิชาบริ หารเภสัชกิจ, คณะ
เภสัชศาสตร์, มหาวิทยาลัยสงขลานคริ นทร์. หน้า 1-121.
สมศักดิ หลีหลัง. (2559). นโยบายทางการเงินของประเทศสหรั ฐอเมริ กาทีมีผลกระทบต่ อราคาหลักทรั พย์ใน
ตลาดหลักทรั พย์ประเทศไทย. ดุษฎีนิพนธ์, ภาควิชาบริ หารธุรกิจ, คณะวิทยาการจัดการ, หน้า 1-280.
Somsak, L. and Supparat, S. (2004). Amphotericin B micelles for drug delivery to the airways.
Project 005559, Department of Pharmaceutical Technology, Faculty of Pharmaceutical
Sciences. Prince of Songkla University. pp. 1 - 49.

Somsak, L. (2013). Pharmacy acquisition costs in Songkhla province. Thesis HD9672.T5,


Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences. Prince of
Songkla University. pp. 1 - 121.

Somsak, L.(2016). Monetary Policy of the United States that Affect on Equity Prices in the
Stock Exchange of Thailand. Dissertation STOU 56823, School of Management Science,
Sukhothai Thammathirat Open University. pp. 1 – 280.

Somsak, L. (2017). Monetary Policy of Developed Countries Transmission in Emerging


Markets: The Case of Thailand. GSB 093524, Graduate School of Business, Universiti
Sains Malaysia. pp. 1 - 449.
Somsak, L.and Surachat, N. (2013). Pharmacy acquisition costs in Songkhla province. Journal
of Pharmacy Research. Vol 7, pp. 429 – 453.

Somsak, L., Gallayanee, P. and Gingporn, T. (2017). Monetary Policy of the United States that
Affect on Equity Prices in the Stock Exchange of Thailand. The Journal of World
Investment & Trade .Vol 18, Issue 1, pp. 87- 97.

Somsak, L., Nabsiah, A. and Ellisha, A. (2017). Monetary Policy of Developed Countries
Transmission in Emerging Markets: The Case of Thailand. Journal of Asian and African
Studies (JASS). Vol 52, Issue 1, pp. 238 – 262.

Somsak, L. (2018). Set50 Index Futures for Investors. Contemporary Asia Arbitration Journal,
Vol 68, No. 2, February, pp. 178 – 191.

Work Experience
June 2004 – February 2005 Pharmacist : Wangbhesajphamaceutical Co., Ltd.
March 2005 – June 2007 Office Manager and Registered Pharmacist :
Moryapharmacy Co.,Ltd
March 2005 – Present Investor in SET and Trader in TFEX.
June 2007 – Present Founder and Registered Pharmacist :
Moryamuangmai.
January 2009 – March 2015 Manager : Azmarbhesaj.
June 2011 – December 2015 Manager : Soonyamuangmai.
December 2014 – Present President : Morya Group Co., Ltd.
November 2017 – Present Agent Manager : Srikrungbroker Co., Ltd.
January 2018 – Present Chief Executive Officer : Doctor Morya Co., Ltd.
Dr. Somsak Leelang Portfolio Tracker

Company Symbol Stake

AIRPORTS OF THAILAND PUBLIC COMPANY LIMITED AOT 5.63%

BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED BDMS 6.04%

BANGKOK EXPRESSWAY AND METRO PUBLIC COMPANY LIMITED BEM 5.15%

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED BH 5.66%

BANGKOK LIFE ASSURANCE PUBLIC COMPANY LIMITED BLA 5.40%

CARABAO GROUP PUBLIC COMPANY LIMITED CBG 5.23%

CP ALL PUBLIC COMPANY LIMITED CPALL 5.46%

CHAROEN POKPHAND FOODS PUBLIC COMPANY LIMITED CPF 5.70%

HOME PRODUCT CENTER PUBLIC COMPANY LIMITED HMPRO 5.34%

INTOUCH HOLDINGS PUBLIC COMPANY LIMITED INTUCH 5.67%

LDC DENTAL PUBLIC COMPANY LIMITED LDC 5.81%

MINOR INTERNATIONAL PUBLIC COMPANY LIMITED MINT 5.72%

QUALITY HOUSES PUBLIC COMPANY LIMITED QH 5.17%

QUALITECH PUBLIC COMPANY LIMITED QLT 5.12%

THE SIAM CEMENT PUBLIC COMPANY LIMITED SCC 6.13%

SPCG PUBLIC COMPANY LIMITED SPCG 5.97%

TOA PAINT (THAILAND) PUBLIC COMPANY LIMITED TOA 5.12%

TMB BANK PUBLIC COMPANY LIMITED TMB 5.68%

APPROVED BY

(Somsak Leelang: PhD, RPh, IC Complex 1)

December 31, 2018

S-ar putea să vă placă și